| HardyDisk AST Tebipenem 10µg (TBP10)K262113 · JTN | Hardy Diagnostics | 510(k) | Aug 20, 2026FDA decision date |
| HardyDisk AST Cefiderocol 30g (FDC30) REF Z9435
HardyDisk AST Cefiderocol 30g (FDC30) for in vitro agar diffusion susceptibility testing is ind…Z-2887-2026 · JTN | Hardy Diagnostics | Recall | Aug 5, 2026FDA classification date |
| Thermo Scientific Oxoid Cefepime/Zidebactam Disc (30/30 µg) FPZ60K261781 · JTN | Thermo Fisher Scientific (Oxoid Ltd.) | 510(k) | Jul 24, 2026FDA decision date |
| Gepotidacin GEP 10 µgK261853 · JTN | Liofilchem, Inc. | 510(k) | Jul 23, 2026FDA decision date |
| HardyDisk AST Gepotidacin 10µg (GEP10)K260842 · JTN | Hardy Diagnostics | 510(k) | May 11, 2026FDA decision date |
| Thermo Scientific Oxoid Gepotidacin Disc (10 µg) GEP10K251337 · JTN | Thermo Fisher Scientific (Oxoid Ltd.) | 510(k) | Dec 5, 2025FDA decision date |
| HardyDisk AST Cefiderocol 30µg (FDC30)K253105 · JTN | Hardy Diagnostics | 510(k) | Nov 20, 2025FDA decision date |
| Sulopenem SPM 2 µgK251879 · JTN | Liofilchem | 510(k) | Aug 12, 2025FDA decision date |
| HardyDisk AST Gepotidacin 10µg (GEP10)K250956 · JTN | Hardy Diagnostics | 510(k) | Jun 26, 2025FDA decision date |
| Ceftobiprole BPR 5 µg DiscK250885 · JTN | Liofilchem, Inc. | 510(k) | Jun 23, 2025FDA decision date |
| Thermo Scientific Oxoid Aztreonam/Avibactam Disc (30/20 µg) AZA50K250789 · JTN | Thermo Fisher Scientific (Oxoid Ltd.) | 510(k) | Jun 12, 2025FDA decision date |
| HardyDisk Aztreonam/Avibactam 30/20µg (AZA50)K250454 · JTN | Hardy Diagnostics | 510(k) | May 15, 2025FDA decision date |
| Lev5, REF CT1587B, 50 Susceptibility discs Levofloxacin 5 ug, IVD, CE 2797Z-1075-2025 · JTN | Oxoid Limited | Recall | Feb 4, 2025FDA classification date |
| BD BBL Sensi Disc Ampicillin 2 g (AM-2) - In-Vitro BD BBL Sensi Disc Ampicillin 2 g (AM-2) are used for semi-quantitative in vitro susceptibility…Z-0621-2025 · JTN | Becton Dickinson & Co. | Recall | Dec 5, 2024FDA classification date |
| HardyDisk AST Cefiderocol 30µg (FDC30)K241060 · JTN | Hardy Diagnostics | 510(k) | Jul 18, 2024FDA decision date |
| Thermo Scientific Oxoid Rezafungin Disc (5 µg) RZF5K231806 · JTN | Oxoid Limited (Part of Thermo Fisher Scientific) | 510(k) | Mar 22, 2024FDA decision date |
| Sensi Disc Amoxicillin with Clavulanic Acid 20/10 g, Catalog No. 231628 and 231629.
These discs are used for semi-quantitative in vitro suscept…Z-1011-2024 · JTN | Becton Dickinson & Co. | Recall | Feb 8, 2024FDA classification date |
| BD BBL Sensi Disc Ampicillin - 10 g, Catalog No. 230705 and 231264; 2 g, Catalog No. 231263. Used for semi-quantitative in vitro susceptibility t…Z-1012-2024 · JTN | Becton Dickinson & Co. | Recall | Feb 8, 2024FDA classification date |
| BD BBL Sensi Disc Ampicillin with Sulbactam 10/10 g, Catalog Number 231660. Used for semi-quantitative in vitro susceptibility testing.Z-1013-2024 · JTN | Becton Dickinson & Co. | Recall | Feb 8, 2024FDA classification date |
| BD BBL Sensi Disc Augmentin - 3g, Catalog Number 291270used for semi-quantitative in vitro susceptibility testing.Z-1014-2024 · JTN | Becton Dickinson & Co. | Recall | Feb 8, 2024FDA classification date |
| BD BBL Sensi Disc Azithromycin -15 g, Catalog Number 231682used for semi-quantitative in vitro susceptibility testing.Z-1015-2024 · JTN | Becton Dickinson & Co. | Recall | Feb 8, 2024FDA classification date |
| BD BBL Sensi Disc Aztreonam - 30 ug, used for semi-quantitative in vitro susceptibility testing. Catalog Numbers 231640and 231641.Z-1016-2024 · JTN | Becton Dickinson & Co. | Recall | Feb 8, 2024FDA classification date |
| BD BBL Sensi Disc Cefaclor - 30 ug, used for semi-quantitative in vitro susceptibility testing. Catalog Number 231653Z-1017-2024 · JTN | Becton Dickinson & Co. | Recall | Feb 8, 2024FDA classification date |
| BD BBL Sensi Disc Cefepime - 30 ug, used for semi-quantitative in vitro susceptibility testing. Catalog Number 231696Z-1018-2024 · JTN | Becton Dickinson & Co. | Recall | Feb 8, 2024FDA classification date |
| BD BBL Sensi Disc Cefixime - 5 ug, used for semi-quantitative in vitro susceptibility testing. Catalog Number 231664Z-1019-2024 · JTN | Becton Dickinson & Co. | Recall | Feb 8, 2024FDA classification date |